TEMPOS is a user-friendly rating scale that can be used to assess adherence to reporting recommendations.
Blog
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
Nitasha is a clinical research coordinator in the Dunn Lab and a fan of the Marvel comic book movies.
Mass General researcher Paola Pedrelli, PhD, is testing a new approach for remotely monitoring patients with depression.
Alzheimer's Disease, Cardiology, Depression, Endowed MGH Research Institute Chairs | 0 comment | 23 February, 2021 | 1
The COVID-19 pandemic is only the most recent example of the central role that sex and gender play in major medical illness.
The Women in Science (WiS) group within the Martinos Center for Biomedical Imaging was created to generate thoughtful conversation about disparities in STEM related to gender & gender identity, culture, race, sexual orientation. The group recently hosted a webinar called “Mental Health from PIs to Mentees” to discuss the importance of mental health and self-careRead more
Rudy Tanzi, PhD, shares science-backed mindfulness tips to promote brain health and reduce stress as the pandemic continues.
Opioids can be an effective painkiller following major surgery but prescribing them is not without risk.
A nationwide study co-led by Mass General researchers found high levels of worry, frustration, boredom and anxiety.
When a person is infected with COVID-19, the first thing a physician will advise is to self-isolate and stay home. But what if home isn’t safe?